CIK: 0001710065
Total reported value
—
Reporting period: 2026-06-30 · Number of holdings: 1
AJU IB Investment Co., Ltd. disclosed 1 holdings in its latest 13F filing for the period ending 2026-06-30, with total reported value of — and a quarterly turnover rate of 100.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Sold out ACLXGBX
Sold out KYMR
Sold out SEER
Sold out RLYB
Sold out STRO
Sold out XLO
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Ikena Oncology INC | Stock-Other | — | — | — |
Performance for Q3 2026
—
Performance Last 4 Quarters
—
Based on 0 months of available history
Based on 9% of reported portfolio value with available pricing
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-06-30 | 1 | — | 100 | |
| 2026-03-31 | 6 | $30.5M | 66 | |
| 2025-12-31 | 7 | $22.8M | 100 | |
| 2025-09-30 | 7 | $115.1M | 100 | |
| 2025-06-30 | 8 | $91.9M | 0 | |
| 2025-03-31 | 8 | $84.0M | 100 | |
| 2024-12-31 | 8 | $102.8M | 100 | |
| 2022-09-30 | 7 | $58.4M | 0 | |
| 2022-06-30 | 7 | $51.6M | 0 | |
| 2022-03-31 | 7 | $64.8M | 0 | |
| 2021-12-31 | 6 | $71.8M | 0 | |
| 2021-09-30 | 11 | $155.0M | 0 | |
| 2021-06-30 | 11 | $173.4M | 100 | |
| 2021-03-31 | 11 | $265.1M | 32 | |
| 2020-12-31 | 11 | $264.3M | — |
AJU IB Investment Co., Ltd.'s most significant position changes for 2026-06-30: Sold out: Arcellx INC (ACLXGBX); Sold out: Kymera Therapeutics INC (KYMR); Sold out: Seer INC (SEER); Sold out: Rallybio CORP (RLYB); Sold out: Sutro Biopharma, Inc. (STRO).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | — | EXIT | Sold out |
| 2 | KYMR | Kymera Therapeutics INC | — | EXIT | Sold out |
| 3 | SEER | Seer INC | — | EXIT | Sold out |
| 4 | RLYB | Rallybio CORP | — | EXIT | Sold out |
| 5 | STRO | Sutro Biopharma, Inc. | — | EXIT | Sold out |
| 6 | XLO | Xilio Therapeutics INC | — | EXIT | Sold out |
| 7 | ✓ | Ikena Oncology INC | — | — | Unchanged |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-06-30 | 2026-07-16 | 13F-HR | View on EDGAR |
| 2026-03-31 | 2026-05-08 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-10 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-06 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-07-10 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-04-08 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-04-08 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | Amendment | View on EDGAR |
| 2022-09-30 | 2022-11-07 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-09 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-12 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-09 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-10 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-10 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-12 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-05-12 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0000048966
Total reported value
—
1 stks
2024-12-31
Stale — no recent filing
CIK 0000056822
Total reported value
—
1 stks
2019-12-31
Stale — no recent filing
CIK 0000083402
Total reported value
—
1 stks
2021-09-30
Stale — no recent filing